Literature DB >> 25609381

PD-L1hi B cells are critical regulators of humoral immunity.

Adnan R Khan1, Emily Hams1, Achilleas Floudas1, Tim Sparwasser2, Casey T Weaver3, Padraic G Fallon4.   

Abstract

Specific B-cell subsets can regulate T-cell immune responses, and are termed regulatory B cells (Breg). The majority of Breg cells described in mouse and man have been identified by IL-10 production and are known to suppress allergy and autoimmunity. However, Breg cell mediated immune suppression, independent of IL-10, also occurs. Here we show that Breg cells play a critical role in regulating humoral immunity mediated by CD4(+)CXCR5(+)PD-1(+) follicular helper T cells, and can suppress inflammation in autoimmune disease through elevated expression of PD-L1. We have also identified that these B cells are resistant to αCD20 B-cell depletion. This work describes how Breg cells are critical in humoral homoeostasis and may have implications for the regulation of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25609381     DOI: 10.1038/ncomms6997

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  115 in total

Review 1.  Immune Checkpoint Blockade and Hematopoietic Stem Cell Transplant.

Authors:  Reid W Merryman; Philippe Armand
Journal:  Curr Hematol Malig Rep       Date:  2017-02       Impact factor: 3.952

2.  High macrophage PD-L1 expression not responsible for T cell suppression.

Authors:  Naomi Goldman; Yelizavet D Lomakova; Jennifer Londregan; Amanda Bucknum; Kelley DePierri; John Somerville; James E Riggs
Journal:  Cell Immunol       Date:  2017-12-30       Impact factor: 4.868

Review 3.  Immunoplasticity in cutaneous melanoma: beyond pure morphology.

Authors:  Francesca Maria Bosisio; Joost J van den Oord
Journal:  Virchows Arch       Date:  2017-01-05       Impact factor: 4.064

4.  Translation control of the immune checkpoint in cancer and its therapeutic targeting.

Authors:  Yichen Xu; Mauro Poggio; Hyun Yong Jin; Zhen Shi; Craig M Forester; Ying Wang; Craig R Stumpf; Lingru Xue; Emily Devericks; Lomon So; Hao G Nguyen; Alice Griselin; John D Gordan; Sarah E Umetsu; Siegfried H Reich; Stephen T Worland; Saurabh Asthana; Maria Barna; Kevin R Webster; John T Cunningham; Davide Ruggero
Journal:  Nat Med       Date:  2019-01-14       Impact factor: 53.440

5.  Obesity affects peripheral lymphoid organs immune response in murine asthma model.

Authors:  Erick Esteves de Oliveira; Flávia Márcia de Castro E Silva; Marina Caçador Ayupe; Marcilene Gomes Evangelista Ambrósio; Viviane Passos de Souza; Gilson Costa Macedo; Ana Paula Ferreira
Journal:  Immunology       Date:  2019-07       Impact factor: 7.397

Review 6.  Signals that drive T follicular helper cell formation.

Authors:  Louise M C Webb; Michelle A Linterman
Journal:  Immunology       Date:  2017-07-17       Impact factor: 7.397

Review 7.  Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies.

Authors:  Yi Xia; L Jeffrey Medeiros; Ken H Young
Journal:  Biochim Biophys Acta       Date:  2015-10-16

Review 8.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

9.  Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.

Authors:  Eduardo Huarte; SangMu Jun; Agnieszka Rynda-Apple; Sara Golden; Larissa Jackiw; Carol Hoffman; Massimo Maddaloni; David W Pascual
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

Review 10.  Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors.

Authors:  David J Lee; Howard J Lee; Jocelyn R Farmer; Kerry L Reynolds
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.